Recovery of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG) plasma concentrations during remission in patients suffering from atopic dermatitis

Platelets

Volumn 21, Issue 7, 2010, Pages 522-524

  Kasperska Zajac, Alicja ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

atopic dermatitis; beta thromboglobulin; Platelet activation; platelet factor 4

Indexed keywords

BETA THROMBOGLOBULIN; THROMBOCYTE FACTOR 4;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; THROMBOCYTE ACTIVATION;

EID: 77958016119     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2010.493247     Document Type: Article

References (14)

1. Kasperska-Zajac A, Rogala B. Platelet function in anaphy-laxis. J Invest Allergol Clin Immunnol 2006;16:1-4.
2. Kasperska-Zajac A, Rogala B. Platelet activation during allergic inflammation. Inflammation 2007;30:161-166.
3. Kasperska-Zajac A, Rogala B, Nowakowski M. Assessment of platelet activity, expressed by plasma levels of platelet factor 4 and beta-thromboglobulin in patients with chronic idiopathic urticaria. Exp Dermatol 2005;14:515-518.
4. Hilger RA, Neuber K, Konig W. Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis. Immunology 1991;74:689-695.
5. Neuber K, Hilger RA, König W. Differential increase in 12-HETE release and CD29/CD49f expression of platelets from normal donors and from patients with atopic dermatitis. Int Arch Allergy Immunol 1992;98:339-342.
6. Kasperska-Zajac A, Brzoza Z, Rogala B. Increased concentration of platelet-derived chemokines in serum of patients with delayed pressure urticaria. Eur Cytokine Netw 2008;19:89-91.
7. Kasperska-Zajac A, Brzoza Z, Rogala B. Platelet function in cutaenous diseases. Platelets 2008;19:317-321.
8. Kasperska-Zajac A, Rogala B. Markers of platelet activation in plasma of patients suffering from persistent allergic rhinitis with or without asthma symptoms. Clin Exp Allergy 2005;35:1462-1465.
9. Kasperska-Zaja?c A, Rogala B. Platelet activity measured by plasma levels of beta-thromboglobulin and platelet factor 4 in seasonal allergic rhinitis during natural pollen exposure. Inflamm Res, 2003,52,477-479.
10. Watanabe O, Natori K, Tamari M, Shiomoto Y, Kubo S, Nakamura Y. Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis. J Hum Genet 1999;44:173-176.
11. Bruijnzeel PL, Kuijper PH, Rihs S, Betz S, Warringa RA, Koenderman L. Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4. J Invest Dermatol 1993;100:137-142.
12. Kasperska-Zajac A, Nowakowski M, Rogala B. Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome. Inflammation 2004;28:299-302.
13. Tamagawa-Mineoka R, Katoh N, Ueda E, Masuda K, Kishimoto S. Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4. Allergol Int 2008;57:391-396.
14. Rajka G, Lageland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol 1989;144(Suppl):13-14.